We are live on ! Find out more
NMRD

Nemaura Medical, Inc. Common Stock
NMRD

Delisted

NMRD was delisted on the 4th of January, 2024.

Back to rankings

2 hedge funds and large institutions have $1.85K invested in Nemaura Medical, Inc. Common Stock in 2024 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

90% less funds holding

Funds holding: 21 → 2 (-19)

99% less capital invested

Capital invested by funds: $281K → $1.85K (-$279K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 19

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
2
Holders Change
-19
Holders Change %
-90.48%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
1
Closed
19
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$185K
2
Vanguard Group
Vanguard Group
Pennsylvania
-$27.7K
3
Geode Capital Management
Geode Capital Management
Massachusetts
-$24.3K
4
State Street
State Street
Massachusetts
-$12.1K
5
Citadel Advisors
Citadel Advisors
Florida
-$9.38K

NMRD Hedge Fund Activity: Q1 2024 in Review

2 of the 6,958 institutional investors tracked by Wall St. Rank reported a position in Nemaura Medical, Inc. Common Stock (NMRD) for Q1 2024, worth a combined $1.85K — down 99% from $281K a quarter earlier.

Sellers outnumbered buyers: 19 funds closed out of NMRD and 0 opened new positions — a net loss of 19 holders — while 1 trimmed existing stakes and 0 added.

The largest seller was Alyeska Investment Group, exiting entirely with an estimated $185K sold.

  • 2 institutional investors held Nemaura Medical, Inc. Common Stock (NMRD) as of Q1 2024, down from 21 in Q4 2023.
  • Funds reported $1.85K of Nemaura Medical, Inc. Common Stock stock for Q1 2024, down 99% quarter-over-quarter.
  • 0 funds opened new Nemaura Medical, Inc. Common Stock positions in Q1 2024 and 19 closed out, a net change of -19 holders.
  • The largest Nemaura Medical, Inc. Common Stock seller in Q1 2024 was Alyeska Investment Group, an estimated $185K sold.

Based on aggregated 13F filings for Q1 2024.